Abstract
Structural characterization of antigen-antibody interactions is critical for understanding
protective vaccine responses and development of therapeutic monoclonal antibodies (mAb).
Traditional biophysical and biochemical techniques often require the immobilization of one binding
partner or provide ensemble-averaged measurements, constraints which may limit the ability to probe
multiple facets of antigen-antibody interactions. Native mass spectrometry (MS) offers a versatile
alternative, providing a comprehensive view of antigen-antibody complexes. Here, we utilized native
MS to screen the interactions between a small panel of monoclonal antibodies (mAbs) and the
Bordetella pertussis vaccine antigen mature pertactin (Prn), offering an in-depth characterization of
binding stoichiometry, cooperativity, and competition. We implemented variable temperature
electrospray ionization to evaluate thermal induced unfolding and stability of different mAb•Prn
complexes, while biolayer interferometry (BLI) and competition experiments were employed to provide
complementary information about binding kinetics and mapping of distinct epitopes on Prn. Finally, we
used native MS to evaluate the interactions of individual mAbs with Prn variants as a predictor for
therapeutic action. Our results demonstrate the utility of native MS, in combination with
complementary techniques, as a powerful approach for understanding the interactions of protective
mAbs binding Prn, which can ultimately contribute to the development of more effective vaccines to
prevent pertussis infection.
Supplementary materials
Title
Screening pertactin-specific antibodies and evaluating competitive epitope recognition by native mass spectrometry
Description
The supporting file contains expanded experimental methods and additional data that support the native mass spectrometry-based characterization of pertactin (Prn) and its interactions with therapeutic monoclonal antibodies (mAbs).
Actions